Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 14,068 shares at $110.31 ($1.6M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($1.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.31 | 6,984 | $770K | 49.6% |
| 2 | $110.31 | 6,984 | $770K | 49.6% |
| 3 | $111.32 | 100 | $11K | 0.7% |
| Total | $110.32 avg | 14,068 | $1.6M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |